Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer

Journal of Clinical Oncology

Volumn 18, Issue 22, 2000, Pages 3775-3781

  Baekelandt, M ^a   Holm, R ^a   Nesland, J M ^a   Trope C G ^a   Kristensen, G B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL X; PROTEIN MCL 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASCITES; CANCER STAGING; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL; TUMOR BIOPSY; TUMOR DIFFERENTIATION;

EID: 0034669625     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.22.3775     Document Type: Article

References (37)

1. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics
2. Clinical multidrug resistance in cancer: A multifactorial problem
3. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
4. Apoptosis and chemotherapy resistance
5. Life, death, and the pursuit of apoptosis
6. Molecular thanatopsis: A discourse on the Bcl-2 family and cell death
7. Bcl-2 family proteins
8. Double identity for proteins of the Bcl-2 family
9. Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene
10. Induction of Bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis
11. Bax enhances paclitaxel-induced apoptosis through a p53-independent pathway
12. Bax directly induces release of cytochrome c from isolated mitochondria
13. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
14. Bcl-X(L) forms an ion channel in synthetic lipid membranes
15. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions
16. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes
17. The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer
18. Clinical significance of apoptosis-related proteins p53, Mdm-2, and Bcl-2 in advanced ovarian cancer
19. Chemotherapy versus radiotherapy as consolidation treatment of ovarian carcinoma stage III at surgical complete remission from induction chemotherapy
20. Non-parametric estimation from incomplete observations
21. Regression models and life tables (with discussion)
22. Bax protein expression and clinical outcome in epithelial ovarian cancer
23. Differential expression of apoptosis associated genes Bax and Bcl-2 in ovarian cancer
24. Bcl-2, Bax, Bcl-x(L), and Bcl-x(S) expression in normal and neoplastic ovarian tissues
25. Immunohistochemical analysis of Bcl-2, Bax, Mcl-1, and bcl-x expression in ovarian surface epithelial tumors
26. Expression and localization of Bcl-2 related proteins in human ovarian cancers
27. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers
28. Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma
29. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the Bax gene
30. Expression of Bcl-x(L) can confer a multidrug resistance phenotype
31. Bcl-X(L) is heterogeneously expressed by acute myeloblastic leukemia cells and is associated with autonomous growth in vitro and with P-glycoprotein expression
32. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses
33. 2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids
34. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry
35. Bcl-2 expression, p53 accumulation, and apoptosis in ovarian carcinomas
36. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma
37. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence